About Us Our leading SaaS-based Global Employment Platform enables clients to expand into over 180 countries quickly and efficiently, without the complexities of establishing local entities. At G-P, we’re dedicated to breaking down barriers to global
Founded in 1946, Fidia is an Italian multinational pharmaceutical company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio, mainly based on Hyaluronic Acid, in strategic therapeutic areas such as Joint care, Eye
Founded in 1946, Fidia is an Italian multinational pharmaceutical company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio, mainly based on Hyaluronic Acid, in strategic therapeutic areas such as Joint care, Eye
Founded in 1946, Fidia is an Italian multinational pharmaceutical company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio, mainly based on Hyaluronic Acid, in strategic therapeutic areas such as Joint care, Eye
Founded in 1946, Fidia is an Italian multinational pharmaceutical company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio, mainly based on Hyaluronic Acid, in strategic therapeutic areas such as Joint care, Eye
Founded in 1946, Fidia is an Italian multinational pharmaceutical company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio, mainly based on Hyaluronic Acid, in strategic therapeutic areas such as Joint care, Eye
Founded in 1946, Fidia is an Italian multinational pharmaceutical company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio, mainly based on Hyaluronic Acid, in strategic therapeutic areas such as Joint care, Eye
ENERCON has been one of the technology leaders in the wind power sector for 40 years. As the first manufacturer of wind turbines, the company used a gearless drive concept that is a characteristic of all ENERCON
Founded in 1946, Fidia is an Italian multinational pharmaceutical company, with R& D, manufacturing, marketing and sales capabilities, and an extensive product portfolio, mainly based on Hyaluronic Acid, in strategic therapeutic areas such as Joint care,
Parexel is pleased to announce we are looking to hire several CRA II for the team in Italy. Candidates must have close to atleast 2 years independent monitoring experience in a similar setting. The role can
Company DescriptionArtisan of travel since 1883, Orient Express sublimates the art of travel with its luxury trains, hotels, and sailing yachts. The brand has just launched its first hotel, Orient Express La Minerva, in Rome – which
Our leading SaaS-based Global Employment Platform enables clients to expand into over 180 countries quickly and efficiently, without the complexities of establishing local entities. At G-P, we’re dedicated to breaking down barriers to global business and
Our leading SaaS-based Global Employment Platform enables clients to expand into over 180 countries quickly and efficiently, without the complexities of establishing local entities. At G-P, we’re dedicated to breaking down barriers to global business and
RemoFirst is transforming the way businesses hire and manage global teams. Our mission is to enable Freedom of Work by providing an all-in‑one global HR platform that simplifies hiring, compliance, payroll, and benefits management. We partner
The Clinical Research Associate is the clinical sites’ direct point of contact and accountable for managing site quality and delivery from site identification through close-out. The aim of this role is to build the relationship with
Organisation/Company Università degli Studi di Trento Research Field Engineering Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 30 Jun 2026 - 16:00 (UTC) Country Italy Type of Contract
Senior/Executive Medical Director, Clinical Development, Solid Tumors Responsibilities The Senior/Executive Medical Director, Clinical Development, Solid Tumors will be responsible for driving the global clinical development strategy in solid tumors, specifically Stemline’s Breast Cancer product, Elecestrant. The
ENERCON has been one of the technology leaders in the wind power sector for 40 years. As the first manufacturer of wind turbines, the company used a gearless drive concept that is a characteristic of all ENERCON